ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,000.00
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      82.005
      -2.47%
      Bitcoin
      67,002.83
      4.74%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Telesis Bio Inc (TBIO) Quote

      Telesis Bio Inc

      Telesis Bio Inc (TBIO)

      NASDAQ
      4.00
      -0.185
      (-4.42%)
      At close: July 19 4:00PM
      Delayed by 15 minutes
      4.11
      0.11
      ( 2.75% )
      After Hours: 4:07PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      4.11
      Bid
      4.00
      Ask
      4.45
      Volume
      11,443
      3.90 Day's Range 4.16
      3.025 52 Week Range 29.34
      Market Cap
      7.042M
      Previous Close
      4.185
      Open
      4.10
      Last Trade
      200
      @
      4.11
      (formt)
      Last Trade Time
      16:00:01
      Financial Volume
      $ 46,046
      VWAP
      4.024
      Average Volume (3m)
      94,556
      Shares Outstanding
      1,682,794
      Dividend Yield
      -
      PE Ratio
      -0.14
      Earnings Per Share (EPS)
      -29.13
      Revenue
      27.51M
      Net Profit
      -49.02M

      About Telesis Bio Inc

      Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of virtually error-free DNA and mRNA at a useable scale. Its on-market and planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp DBC, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, BioXp DBC kits, Benchtop reagents and Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS). BioXp 3250 system is a push-button, walkaway, end-to-end automated workstation that offers endpoint-ready synthetic DNA in as few as 8 hours and mRNA in less than 24 hours. BioXp DBC is engaged in delivering on-demand enzymatic DNA synthesis with design-to-endpoint-ready synthetic RNA in as few as 24 hours. Show more

      Sector
      Lab Analytical Instruments
      Industry
      Lab Analytical Instruments
      Website
      www.codexdna.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Telesis Bio Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TBIO. The last closing price for Telesis Bio was $4.19. Over the last year, Telesis Bio shares have traded in a share price range of $ 3.025 to $ 29.34.

      Telesis Bio currently has 1,682,794 shares outstanding. The market capitalization of Telesis Bio is $7.04 million. Telesis Bio has a price to earnings ratio (PE ratio) of -0.14.

      TBIO Latest News

      More News

      Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

      23 hours ago
      Edgar (US Regulatory)

      Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

      23 hours ago
      Edgar (US Regulatory)

      Form 8-K - Current report

      24 hours ago
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 12 2024
      Edgar (US Regulatory)

      Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

      June 10 2024
      Edgar (US Regulatory)

      Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

      June 10 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 10 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      May 09 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.617.0940170943.514.363.3488453.67908097CS
      40.5716.10169491533.544.65993.3656813.77835207CS
      12-1.6032-28.0613316535.71327.28823.025945564.98765786CS
      26-1.65-28.64583333335.7615.4623.02542486710.33974259CS
      52-22.53-84.572072072126.6429.343.02528697710.25085412CS
      156-513.93-99.206624971518.04683.733.025554652421.71728592CS
      260-167.61-97.606568833171.72683.733.025736497360.22001684CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NUZENuZee Inc
      $ 1.50
      (31.71%)
      		623
      XCURExicure Inc
      $ 0.6979
      (30.42%)
      		2.5M
      BIORBiora Therapeutics Inc
      $ 0.7499
      (13.02%)
      		720
      PRTGPortage Biotech Inc
      $ 0.2575
      (12.40%)
      		482.14k
      TKNOAlpha Teknova Inc
      $ 2.40
      (11.11%)
      		66.54k
      WRNTWarrantee Inc
      $ 0.28
      (-11.25%)
      		150
      SGDSafe and Green Development Corporation
      $ 0.3325
      (-11.10%)
      		24.26k
      SSKNStrata Skin Sciences Inc
      $ 3.25
      (-9.09%)
      		221.27k
      JCSEJE Cleantech Holdings Limited
      $ 1.17
      (-7.87%)
      		546
      VVOSVivos Therapeutics Inc
      $ 2.29
      (-7.66%)
      		1.05k
      IQiQiyi Inc
      $ 3.50
      (0.29%)
      		3.35M
      TLTiShares 20 plus Year Treasury Bond
      $ 92.97
      (0.02%)
      		3.32M
      XCURExicure Inc
      $ 0.6979
      (30.42%)
      		2.5M
      NVDANVIDIA Corporation
      $ 117.99
      (0.03%)
      		1.89M
      JTAIJet AI Inc
      $ 0.3545
      (-6.64%)
      		1.78M

      TBIO Discussion

      View Posts
      TrendTrade2016 TrendTrade2016 1 week ago
      somebody is getting smoked here
      👍️0
      tw0122 tw0122 1 week ago
      5.50s
      👍️0
      observer21 observer21 1 month ago
      Anyone have a clue as to why the jump today?
      👍️0
      TOM611 TOM611 5 months ago
      Go. TBiO. Life. Enhancing. Patent
      👍️0
      Hikiro Hikiro 5 months ago
      I personally see this consolidating Monday between .55 and .45
      👍️0
      glenn1919 glenn1919 5 months ago
      TBIO...............................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783
      👍️0
      XenaLives XenaLives 5 months ago
      This one scares the crap out of me...

      Imagine replication of COVID ( or the next worst thing) with out a biological matrix.

      December 5, 2023 | LIVE WEBINAR
      Unlocking the Potential of mRNA as a Tool for Immuno-Oncology Therapy Discovery and Development
      Immuno-oncology is a rapidly growing area for therapeutic development. With the adoption of various autologous cell therapies and an increased focus on more broadly applicable allogeneic treatments and multi-specific therapies, the complexity of these development activities is also increasing. With this drive to increased complexity and the inherent risks associated with potential failure in Phase 1 clinical trials, it is critical to have a solid scientific foundation for the development of these next-generation immunotherapies. This talk will focus on how to overcome the limitations associated with traditional viral vector based recombinant TCR gene expression to build hundreds of candidates a week, resulting in improved confidence in screening and lead optimization. With the direct use of mRNA to drive transient modulation of cellular phenotypes, potential candidates can be screened quickly and cost-effectively. Come and learn how immuno-oncology researchers are automating synthetic biolological...



      $TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024
      👍️0
      TOM611 TOM611 5 months ago
      Wow, a patent to clone that’s incredible
      👍️0
      observer21 observer21 5 months ago
      Gosh. Such wisdom. Thanks for enlightening us with that critical information.
      👍️0
      TrendTrade2016 TrendTrade2016 5 months ago
      dilutive bio stocks under 1.00 are like pink sheets on steroids...ya better know how to trade em or you will lose yo money fast!!!
      👍️0
      Invest-in-America Invest-in-America 5 months ago
      TBIO: Right here in my San Diego --- grab some?????
      👍️0
      TrendTrade2016 TrendTrade2016 5 months ago
      Chart plays are never tricky. Stick to bullish stocks. Day trading pop and drops, ya better have skills and understand intraday 60 min charting, order flow and how to spot the shorts.
      👍️0
      TimeFades TimeFades 5 months ago
      Tricky day
      👍️0
      Awl416 Awl416 5 months ago
      New highs AH
      👍️0
      TrendTrade2016 TrendTrade2016 5 months ago
      LETS JUST SAY MOST AH POPS ARE DILUTION, ESPECIALLY THE BIO SPACE.
      👍️0
      TheFinalCD TheFinalCD 5 months ago
      THX
      👍️0
      TimeFades TimeFades 5 months ago
      Another short opp
      👍️0
      TrendTrade2016 TrendTrade2016 5 months ago
      AFTER HOUR DILUTION TAKING PLACE...CHASE AND CRY PLAY!
      👍️0
      Awl416 Awl416 5 months ago
      What leaked?
      👍️0
      Zorro Zorro 5 months ago
      Nice one!
      👍️0
      Invest-in-America Invest-in-America 5 months ago
      TBIO: VIBRIO NATRIEGENS (So, what's NEW, Pussycat??!!)

      👍️0
      TheFinalCD TheFinalCD 5 months ago
      $TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024
      👍️0
      observer21 observer21 6 months ago
      Anyone know why the huge jump in price and volume?
      👍️0

      Your Recent History

      NASDAQ
      TBIO
      Telesis Bio
      Delayed Upgrade Clock